In my experience following the evolution of AI in clinical research, one of the most pressing concerns is the phenomenon known as AI hallucination—where AI systems generate outputs that are incorrect or misleading. This issue is critical because clinical research demands the highest level of accuracy and reliability to protect patients. The humorous phrase seen often, “AI hallucinates and that’s why I have job security,” reflects the ongoing human need to oversee AI outputs vigilantly. It’s clear that while AI tools have made significant strides, their ability to completely eliminate hallucinations remains limited. Therefore, relying solely on autonomous AI without sufficient human intervention might be premature, especially in fields where errors can directly affect patient health outcomes. In practice, I’ve noticed that successful implementations involve layered verification processes where AI is used to augment, not replace, expert judgment. Regulators, researchers, and patients all have vital roles in this ecosystem. Setting a high bar reflects prioritizing what patients deserve rather than settling for the current technological capabilities. For instance, regulatory bodies increasingly emphasize transparency, explainability, and accountability in AI-driven clinical applications. Additionally, involving patients in discussions about AI deployment helps ensure that ethical concerns and fears are addressed. From a practical standpoint, continuous training of AI models with updated, diverse datasets and integrating feedback loops where inconsistencies trigger immediate review are measures that can reduce hallucinations. However, human oversight remains indispensable to ensure that patient safety is never compromised. Ultimately, the path forward requires a collaborative approach grounded in ethical principles, technological advancement, and constant vigilance. This approach not only safeguards patients but also builds trust in AI’s role within clinical research.